Advances in the Diagnosis and Treatment of Glaucoma
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Ophthalmology".
Deadline for manuscript submissions: 15 December 2025 | Viewed by 58
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue focuses on the latest innovations and emerging strategies in the diagnosis and treatment of glaucoma, a leading cause of irreversible blindness worldwide. With the advent of advanced imaging modalities, such as optical coherence tomography (OCT) and OCT angiography, clinicians are now better equipped to detect glaucoma at its earliest stages. Artificial intelligence and machine learning algorithms are further enhancing diagnostic precision and disease monitoring. On the therapeutic front, the issue highlights novel pharmacologic agents, sustained-release drug delivery systems, and the growing role of minimally invasive glaucoma surgeries (MIGS). It also explores personalized medicine approaches, including genetic profiling, neurodegeneration, and neuroprotective therapies, aimed at preserving vision beyond intraocular pressure control. By bringing together cutting-edge research and clinical perspectives, this issue aims to inform and inspire advancements in glaucoma management, improve patient outcomes, and encourage continued innovation in ophthalmology.
Dr. Alessio Martucci
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- OCT
- glaucoma
- MIGS
- neuroprotection
- drug delivery systems
- artificial intelligence
- pharmacologic agents
- per-sonalized medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
